| Literature DB >> 28602827 |
Li Tang1, Hong-Yan Chen1, Ning-Bo Hao1, Bo Tang1, Hong Guo1, Xin Yong1, Hui Dong1, Shi-Ming Yang2.
Abstract
MicroRNA (miRNAs) is post-transcriptional regulator of mRNA. However, the prevalence and activity of miRNA are regulated by other regulators. miRNA inhibitors are natural or artificial RNA transcripts that sequestrate miRNAs and decrease or even eliminate miRNA activity. Competing endogenous RNAs (ceRNAs) are natural and intracellular miRNA inhibitors that compete to bind to shared miRNA recognition elements (MREs) to decrease microRNA availability and relieve the repression of target RNAs. In recent years, studies have revealed that ceRNA crosstalk is involved in many pathophysiological processes and adds a new dimension to miRNA regulation. Artificial miRNA inhibitors are RNA transcripts that are synthesized via chemical and genetic methods. Artificial miRNA inhibitors can be used in miRNA loss-of-function research and gene therapies for certain diseases. In this review, we summarize the recent advances in the two different types of miRNA inhibitors.Keywords: Anti-miRNA oligonucleotide; Circular RNA; Competing endogenous RNA; Gene therapy; Nanoparticle; miRNA sponge
Mesh:
Substances:
Year: 2017 PMID: 28602827 DOI: 10.1016/j.canlet.2017.05.025
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679